ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/07/2026
Voltar para busca
Dado oficial do USPTO
NIGHT FEVER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
02/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
30/11/2021
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
02/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
FR
Examinador
ANGOTTI, SALVATORE JOHN
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
BIOFAR
Representantes
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsdietetic foods adapted for medical usedietetic substances adapted for paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparationsparapharmaceutical products and food supplements for medical and paramedical usepharmaceutical preparationsparapharmaceutical products and food supplements for medical and paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products made from plantsextracts of plants and vegetable extracts in effervescent and other forms for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products containing minerals and vitamins in effervescent and other forms; vitamins and minerals in effervescent and other formsgranules; pharmaceutical preparations and parapharmaceutical products for phytotherapy; food supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use for enhancing energy production in the body as additions to the nutrient intake in a normal dietwhich may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; all dietetic substances adapted for medical and paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; food supplements for medical use prepared for human consumption from food ingredients of vegetable and mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable and mineral originwhich may contain proteinscarbohydrateslipidsfibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; fortifying foodstuffs for medical use; fortifying foodstuffs for paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/04/2025
FIMP
FINAL DISPOSITION PROCESSED
18/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2024
PUBO
PUBLISHED FOR OPPOSITION
24/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2024
GNRT
NON-FINAL ACTION E-MAILED
10/01/2024
CNRT
NON-FINAL ACTION WRITTEN
10/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2023
GNRT
NON-FINAL ACTION E-MAILED
10/07/2023
CNRT
NON-FINAL ACTION WRITTEN
10/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/05/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/05/2023
RFNT
REFUSAL PROCESSED BY IB
11/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/11/2022
RFRR
REFUSAL PROCESSED BY MPU
21/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/09/2022
CNRT
NON-FINAL ACTION WRITTEN
19/09/2022
DOCK
ASSIGNED TO EXAMINER
09/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
27/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NIGHT FEVER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.